Stocks and Investing Stocks and Investing
Thu, February 15, 2024

Joseph Stringer Reiterated (ALNY) at Strong Buy and Held Target at $200 on, Feb 15th, 2024


Published on 2024-10-28 08:59:14 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $200 on, Feb 15th, 2024.

Joseph has made no other calls on ALNY in the last 4 months.



There are 6 other peers that have a rating on ALNY. Out of the 6 peers that are also analyzing ALNY, 3 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $176 on, Tuesday, February 13th, 2024
  • Jessica Fung of "JP Morgan" Maintained at Hold with Increased Target to $170 on, Thursday, February 1st, 2024
  • Tiago Fauth of "Wells Fargo" Initiated at Hold and Held Target at $171 on, Friday, December 8th, 2023


These are the ratings of the 3 analyists that currently disagree with Joseph


  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $235 on, Wednesday, February 14th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $395 on, Friday, December 15th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $217 on, Thursday, December 14th, 2023
Contributing Sources